| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012508687 |
| P356 | DOI | 10.1038/SJ.JP.7211103 |
| P698 | PubMed publication ID | 15085166 |
| P5875 | ResearchGate publication ID | 8618497 |
| P2093 | author name string | James E Ferguson | |
| John Kattwinkel | |||
| Melinda Robinson | |||
| Paula Delmore | |||
| Barry T Bloom | |||
| P2860 | cites work | Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network | Q28145522 |
| Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. | Q31083968 | ||
| Lung development and function in preterm infants in the surfactant treatment era. | Q33938812 | ||
| Respiratory distress syndrome mortality in the United States, 1987 to 1995. | Q34081593 | ||
| Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. | Q34223600 | ||
| Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group | Q34334293 | ||
| Systematic review of prophylactic vs rescue surfactant | Q35285796 | ||
| Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant | Q40925547 | ||
| Bronchopulmonary dysplasia and surfactant | Q44439617 | ||
| Leakage of macromolecules in ventilated and unventilated segments of preterm lamb lungs | Q44833723 | ||
| Pharyngeal Deposition of Surfactant in the Premature Rabbit Fetus | Q54645894 | ||
| Leakage of protein in the immature rabbit lung; effect of surfactant replacement | Q69805338 | ||
| Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group | Q69908767 | ||
| Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs | Q71395478 | ||
| Pre- versus post-ventilatory surfactant treatment in surfactant-deficient preterm lambs | Q71632470 | ||
| Lung injury and surfactant metabolism after hyperventilation of premature lambs | Q73530452 | ||
| Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs | Q73667272 | ||
| Nasal prongs continuous positive airway pressure: a simple yet powerful tool | Q74454488 | ||
| Use of continuous positive airway pressure in preterm infants: comments and experience from New Zealand | Q74454491 | ||
| Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial | Q74599264 | ||
| Positive end-expiratory pressure preserves surfactant function in preterm lambs | Q78077608 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 360-365 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Journal of Perinatology | Q18626659 |
| P1476 | title | Technique for intrapartum administration of surfactant without requirement for an endotracheal tube | |
| P478 | volume | 24 |
| Q34170202 | A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams |
| Q38199558 | Adjunctive drug therapies for treatment of respiratory diseases in the newborn: based on evidence or habit? |
| Q51003917 | Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. |
| Q91674525 | Cerebral oxygenation associated with INSURE versus LISA procedures in surfactant-deficient newborn piglet RDS model |
| Q37341712 | Delivery and performance of surfactant replacement therapies to treat pulmonary disorders |
| Q35080714 | Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome |
| Q47244876 | Effect of Surfactant Therapy Using Orogastric Tube for Tracheal Catheterization in Preterm Newborns with Respiratory Distress |
| Q51595579 | Effect of parenterally L-arginine supplementation on the respiratory distress syndrome in preterm newborns. |
| Q35013615 | Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future? |
| Q30227236 | Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions |
| Q36178017 | History of surfactant from 1980. |
| Q24240793 | Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns |
| Q24235572 | Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome |
| Q24241523 | Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome |
| Q47865468 | Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome |
| Q33693537 | Less Invasive Surfactant Administration Reduces the Need for Mechanical Ventilation in Preterm Infants: A Meta-Analysis |
| Q36672200 | Less invasive beractant administration in preterm infants: a pilot study. |
| Q89755493 | Less invasive surfactant administration: best practices and unanswered questions |
| Q47805871 | Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome |
| Q24241781 | Nebulised surfactant for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome |
| Q24198153 | Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome |
| Q38067708 | Novel approaches to surfactant administration |
| Q47783031 | Oropharyngeal surfactant can improve initial stabilisation and reduce rescue intubation in infants born below 25 weeks of gestation |
| Q24235658 | Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome |
| Q24241537 | Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome |
| Q56745849 | Recent Clinical Trials of Surfactant Treatment for Neonates |
| Q37893911 | Surfactant replacement therapy in developing countries |
| Q37106212 | Surfactant therapy: the current practice and the future trends |
| Q37150766 | Surfactants: past, present and future. |
| Q26797273 | The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children |
| Q34538793 | The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation |
| Q38690824 | The evolution of modern respiratory care for preterm infants |
| Q36131235 | The role of surfactant in respiratory distress syndrome |
| Q91010878 | The use of less invasive surfactant administration (LISA) in the United States with review of the literature |
| Q42376024 | Update of minimally invasive surfactant therapy |
| Q36827865 | What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics |
Search more.